Geoffrey M. Fleming

Geoffrey M. Fleming

Auto-generated profile, based on publicly available information

Geoffrey M. Fleming

Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2012 in ASAIO Journal
Verified
Journal Article
Closed access
GFGeoffrey M. Fleming
Geoffrey M. Fleming
DADavid J. Askenazi
David J. Askenazi
BBBrian C. Bridges
Brian C. Bridges
DCDavid S. Cooper
David S. Cooper
MPMathew L. Paden
Mathew L. Paden
MZMichael Zappitelli
Michael Zappitelli
Acute kidney injury and fluid overload (FO) are associated with increased mortality in critically ill patients, including the subset supported with extracorporeal membrane oxygenation (ECMO). The indication for and method of application of renal support therapy (RST) during ECMO is largely unknown beyond single-center experiences. The current study uses a survey design to document practice variation regarding RST, including indication, method of interface with the ECMO circuit, and prescribing practices. Sixty-five international ECMO centers (31%) responded to an online electronic survey regarding RST during ECMO. Nearly a quarter of centers (23%) reported using no RST during ECMO. Among those using the therapy, the predominant mode of therapy applied was convection and included slow continuous ultrafiltration and continuous venovenous hemofiltration. The predominant indication for RST was the treatment (43%) or prevention (16%) of FO. Nephrology rather than critical care medicine is reported as the prescribing service in a majority of centers with a significant difference between US centers and non-US centers. The results of this study identify a wide variation in practice regarding RST during ECMO that will offer multiple important avenues for further research by this group and others regarding the interface of RST and ECMO.

1 December 2016 in Pediatric Critical Care Medicine
Verified
Journal Article
Closed access
GFGeoffrey M. Fleming
Geoffrey M. Fleming
RSRashmi Sahay
Rashmi Sahay
MZMichael Zappitelli
Michael Zappitelli
EKEileen King
Eileen King
DADavid J. Askenazi
David J. Askenazi
DCDavid S. Cooper
David S. Cooper
Objective: In a population of neonatal and pediatric patients on extracorporeal membrane oxygenation; to describe the prevalence and timing of acute kidney injury utilizing a consensus acute kidney injury definition and investigate the association of acute kidney injury with outcomes (length of extracorporeal membrane oxygenation and mortality). Design: Multicenter retrospective observational cohort study. Setting: Six pediatric extracorporeal membrane oxygenation centers. Patients: Pediatric patients (age, < 18 yr) on extracorporeal membrane oxygenation at six centers during a period of January 1, 2007, to December 31, 2011. Interventions: None. Measurements and Main Results: Complete data were analyzed for 832 patients on extracorporeal membrane oxygenation. Sixty percent of patients had acute kidney injury utilizing the serum creatinine Kidney Disease Improving Global Outcomes criteria (AKISCr) and 74% had acute kidney injury using the full Kidney Disease Improving Global Outcomes criteria including renal support therapy (AKISCr + RST). Of those who developed acute kidney injury, it was present at extracorporeal membrane oxygenation initiation in a majority of cases (52% AKISCr and 65% AKISCr + RST) and present by 48 hours of extracorporeal membrane oxygenation support in 86% (AKISCr) and 93% (AKISCr + RST). When adjusted for patient age, center of support, mode of support, patient complications and preextracorporeal membrane oxygenation pH, the presence of acute kidney injury by either criteria was associated with a significantly longer duration of extracorporeal membrane oxygenation support (AKISCr, 152 vs 110 hr; AKISCr + RST, 153 vs 99 hr) and increased adjusted odds of mortality at hospital discharge (AKISCr: odds ratio, 1.77; 1.22–2.55 and AKISCr + RST: odds ratio, 2.50; 1.61–3.90). With the addition of renal support therapy to the model, acute kidney injury was associated with a longer duration of extracorporeal membrane oxygenation support (AKISCr, 149 vs 121 hr) and increased risk of mortality at hospital discharge (AKISCr: odds ratio, 1.52; 1.04–2.21). Conclusion: Acute kidney injury is present in 60–74% of neonatal-pediatric patients supported on extracorporeal membrane oxygenation and is present by 48 hours of extracorporeal membrane oxygenation support in 86–93% of cases. Acute kidney injury has a significant association with increased duration of extracorporeal membrane oxygenation support and increased adjusted odds of mortality at hospital discharge.

1 June 2015 in Academic Medicine
Verified
Journal Article
Closed access
GFGeoffrey M. Fleming
Geoffrey M. Fleming
JSJill H. Simmons
Jill H. Simmons
MXMeng Xu
Meng Xu
SGSabina B. Gesell
Sabina B. Gesell
RBRebekah F. Brown
Rebekah F. Brown
WCWilliam O. Cooper
William O. Cooper
Purpose To explore the design, implementation, and efficacy of a faculty development program in a cohort of early career junior faculty. Method Interested junior faculty members were divided into interdisciplinary small groups led by senior faculty facilitators. The groups met monthly for 1.5 hours to review a modular curriculum from 2011 to 2013. Using a survey at two time points (September 2011 and 2013) and an interim program evaluation, the authors collected data on participants’ demographics, faculty interconnectedness, and self-reported knowledge, skills, and attitudes (KSA) in the domains of professional development and scholarship, including the ability to write career goals and align activities with those goals. Results A total of 104 junior faculty participated in the program. They demonstrated changes in self-reported KSA in the domains of professional development (P = .013, P = .001) and scholarship (P = .038, P = .015) with an increase in ability to write career goals (P < .001), ability to align activities with those goals (P < .001), and number of and amount of time spent pursuing activities related to those goals (P = .022). These changes were more significant among female faculty and were not affected by academic rank or time since last training. Interconnectedness among faculty increased during the period of study—the number of nodes and ties between nodes within the network increased. Conclusions This facilitated peer mentoring program for junior faculty was effective in improving the KSA necessary to promote early career advancement and peer networking, especially for women.

1 January 2011 in Organogenesis
Verified
Journal Article
Closed access
PDF file
GFGeoffrey M. Fleming
Geoffrey M. Fleming
Support of renal function in modern times encompasses a wide array of methods and clinical scenarios, from the ambulatory patient to the critically ill. The ability to safely and routinely deliver ongoing organ support in the outpatient setting has until recently separated renal replacement therapy from other organ support. Renal replacement therapy (RRT) can be applied intermittently or continuously using extracorporeal (hemodialysis) or paracorporeal (peritoneal dialysis) methods. The purpose of this article is to familiarize the reader with the history, physiology, mode, dose, equipment and future of renal replacement therapy and not to detail the technical methods employed for blood purification.

25 June 2008 in Liver Transplantation
Verified
Journal Article
Open access
PDF file
GFGeoffrey M. Fleming
Geoffrey M. Fleming
TCTimothy T. Cornell
Timothy T. Cornell
TWTheodore H. Welling
Theodore H. Welling
JMJohn C. Magee
John C. Magee
GAGail M. Annich
Gail M. Annich
Hepatopulmonary syndrome is an uncommon complication of nonacute liver failure, and in rare cases, hypoxia may be the presenting sign of liver dysfunction. The condition, once thought to be a contraindication, is improved in most cases by transplantation. There is a significant risk of postoperative, hypoxia-related morbidity and mortality in patients with hepatopulmonary syndrome. We present a case of life-threatening hypoxia following liver transplantation for liver failure and associated hepatopulmonary syndrome, with successful management using extracorporeal membrane oxygenation. Liver Transpl 14:966–970, 2008. © 2008 AASLD.

1 September 2012 in Pediatric Critical Care Medicine
Verified
Journal Article
Closed access
GFGeoffrey M. Fleming
Geoffrey M. Fleming
SWScott Walters
Scott Walters
SGStuart L. Goldstein
Stuart L. Goldstein
SASteven R. Alexander
Steven R. Alexander
MBMichelle A. Baum
Michelle A. Baum
PBPatrick D. Brophy
Patrick D. Brophy
Continuous renal replacement therapy is the most often implemented dialysis modality in the pediatric intensive care unit setting for patients with acute kidney injury. However, it also has a role in the management of patients with nonrenal indications such as clearance of drugs and intermediates of disordered cellular metabolism. Using data from the multicenter Prospective Pediatric Continuous Renal Replacement Therapy Registry, we report a cohort of pediatric patients receiving continuous renal replacement therapy for nonrenal indications. Nonrenal indications were obtained from the combination of "other" category for continuous renal replacement therapy initiation and patient diagnosis (both primary and secondary). This cohort was further divided into three subgroups: inborn errors of metabolism, drug toxicity, and tumor lysis syndrome. From 2000 to 2005, a total of 50 continuous renal replacement therapy events with nonrenal indications for therapy were included in the Prospective Pediatric Continuous Renal Replacement Therapy Registry. Indication-specific survival of the subgroups was 62% (inborn errors of metabolism), 82% (tumor lysis syndrome), and 95% (drug toxicity). The median small solute dose delivered among the subgroups ranged from 2125 to 8213 mL/1.73 m/hr, with 54%-59% receiving solely diffusion-based clearance as continuous venovenous hemodialysis. No association was established between survival and dose delivered, modality of continuous renal replacement therapy, or use of intermittent hemodialysis prior to continuous renal replacement therapy. Pediatric patients requiring continuous renal replacement therapy for nonrenal indications are a distinct cohort within the population receiving renal replacement therapy with little published experience of outcomes for this group. Survival within this cohort varies by indication for continuous renal replacement therapy and is not associated with continuous renal replacement therapy modality. Additionally, survival is not associated with small solute doses delivered within a cohort receiving >2000 mL/1.73 m/hr. Our data suggest metabolic control is established rapidly in pediatric patients and that acute detoxification may be provided with continuous renal replacement therapy for both the initial and maintenance phases of treatment using either convection or diffusion at appropriate doses.